EKF, Angle Collaborate for Liquid Biopsy Development | GenomeWeb

NEW YORK (GenomeWeb) – EKF Molecular Diagnostics will collaborate with medical technology firm Angle for liquid biopsy development, the companies announced today.

The UK-headquartered companies aim to initially investigate applications for colorectal cancer diagnostics combining EKF's PointMan DNA enrichment technology with Angle’s Parsortix circulating tumor cell (CTC) harvesting platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.